FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Arab Times8 天
Common painkiller could boost brain power: study
A common painkiller used by millions, ibuprofen, may have additional cognitive benefits, according to a recent study.
FDA approves first new non-opioid pain pill in 20 years—how it works
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Healio18 小时
Q&A: Pain management possible for patients with drug allergies
Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from ...
FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
therookiewire.usatoday10 天
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
Killing pain while boosting your brain! Study finds great effects of Ibuprofen
Ibuprofen, a common painkiller, is found to boost memory and intelligence in a University College London study. While some ...
HealthDay on MSN5 天
FDA Approves First New Non-Opioid Pain Pill in Decades
The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.